Common use

Nintedanib is a potent tyrosine kinase inhibitor and antifibrotic medication used to treat idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and systemic sclerosis-associated ILD. Often recognized as an Ofev generic, nintedanib works by blocking specific enzymes — including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) receptors — that drive the scarring and fibrosis process in lung tissue. By targeting these pathways, nintedanib helps slow the progression of lung scarring and preserves respiratory function over time, giving patients more years of stable breathing capacity. While nintedanib does not cure pulmonary fibrosis or reverse existing lung damage, it is clinically proven to significantly reduce the annual rate of lung function decline in IPF treatment. When you buy Nintedanib online, you are choosing a medication backed by extensive clinical trials that has become a cornerstone of modern interstitial lung disease management worldwide.

Dosage and direction

The standard recommended dose of nintedanib for adults is 150 mg taken orally twice daily, approximately 12 hours apart. Each dose should be taken with food to reduce the likelihood of stomach upset and improve absorption. If side effects such as diarrhea or nausea become intolerable, your doctor may temporarily reduce the dosage to 100 mg twice daily until symptoms improve. Nintedanib capsules should always be swallowed whole with a full glass of water — do not chew, crush, or open the capsules, as this can alter the drug's release mechanism and increase the risk of gastrointestinal irritation. Patients should follow the prescribed schedule exactly and consult their doctor before making any changes to the dosing regimen. Consistent daily use is essential for maintaining the antifibrotic protective effect against progressive lung scarring.

Precautions

Before you buy nintedanib, inform your healthcare provider about your complete medical history. Nintedanib may increase the risk of bleeding events, elevated liver enzymes, and gastrointestinal problems such as persistent diarrhea, nausea, and vomiting. Regular liver function tests are strongly recommended throughout the course of treatment to detect any hepatotoxicity early. Use with particular caution in patients with cardiovascular disease, as nintedanib may carry a risk of arterial thromboembolic events. Patients with hepatic impairment should be monitored more frequently, and those on anticoagulant therapy should be aware of increased bleeding potential. Pregnant women must avoid nintedanib due to demonstrated risk of fetal harm in animal studies — effective contraception should be used during treatment and for at least 3 months after the last dose. Breastfeeding is not recommended during nintedanib therapy.

Contraindications

Nintedanib is contraindicated in patients with a known hypersensitivity to nintedanib, peanut, soya, or any of the excipients in the formulation. It must not be used during pregnancy due to the serious risk of fetal harm, including skeletal and visceral malformations observed in preclinical studies. Patients with severe hepatic impairment (Child-Pugh C) should not take nintedanib, as drug metabolism may be significantly impaired, leading to dangerously elevated blood levels. This medication is not recommended for children or adolescents under 18 years of age, as safety and efficacy have not been established in this population. Always discuss all contraindications with your prescribing physician before beginning IPF treatment with nintedanib.

Possible side effects

The most frequently reported side effect of nintedanib is diarrhea, which occurs in a significant proportion of patients but can usually be managed with adequate hydration, antidiarrheal medications, and dose adjustments. Other common side effects include nausea, vomiting, elevated liver enzymes (ALT and AST), abdominal pain, decreased appetite, and weight loss. Some patients may also experience headache, fatigue, or skin rash during treatment. Rare but serious side effects associated with this tyrosine kinase inhibitor include arterial thromboembolic events (such as heart attack or stroke), gastrointestinal perforation, and significant bleeding complications. Report any signs of serious side effects immediately to your healthcare provider — including black or tarry stools, severe stomach pain, persistent vomiting, jaundice (yellowing of the skin or eyes), chest pain, or sudden difficulty breathing.

Drug interaction

Nintedanib may interact with drugs that affect P-glycoprotein (P-gp) and CYP3A4 metabolic enzymes. Potent P-gp inhibitors such as ketoconazole can increase nintedanib exposure, while P-gp inducers like rifampin may reduce its effectiveness against lung scarring. Co-administration with anticoagulants such as warfarin or heparin may increase the risk of bleeding events. St. John's Wort should be avoided as it can significantly reduce nintedanib blood levels and compromise treatment efficacy. Grapefruit and grapefruit juice should also be avoided during therapy. Always inform your healthcare provider of all medications, over-the-counter drugs, vitamins, and dietary supplements you are using before you buy Nintedanib online or start treatment for interstitial lung disease.

Missed dose

If a dose of nintedanib is missed, it should be skipped entirely, and the next dose taken at the regularly scheduled time. Do not take two doses at once to compensate for the missed one, as this increases the risk of side effects without providing additional therapeutic benefit. Missing doses can reduce the drug's effectiveness in slowing pulmonary fibrosis progression, so maintaining a consistent twice-daily schedule is very important. If you find yourself frequently missing doses, consider setting reminders or discuss strategies with your healthcare provider. If multiple consecutive doses are missed, consult your doctor for guidance on how to safely resume your antifibrotic treatment.

Overdose

Overdose symptoms may include intensified gastrointestinal issues (severe diarrhea, nausea, and vomiting), liver dysfunction with markedly elevated liver enzymes, or increased bleeding risk. There is no specific antidote for nintedanib overdose, so treatment is primarily supportive and symptomatic, focusing on managing dehydration and monitoring organ function. Seek emergency medical attention immediately in the event of a suspected overdose. Always store and use the medication responsibly to avoid accidental misuse. Contact your local poison control center if you believe too much nintedanib has been ingested.

Storage

Store nintedanib capsules at room temperature (20 to 25 degrees C / 68 to 77 degrees F) in a dry place, away from heat and excessive moisture. Keep the capsules in their original container or blister packaging until ready for use to protect them from light and humidity. Do not use expired medication — check expiration dates regularly. Keep nintedanib out of reach of children and pets, and dispose of unused medication according to local pharmaceutical waste regulations.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.